Metagenomi Therapeutics Inc
(MGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,773 | 26,850 | 29,195 | 27,386 | 25,117 |
| Marketable Securities | 151,341 | 178,143 | 196,775 | 220,921 | 249,470 |
| Receivables | 960 | 873 | 1,012 | 1,257 | 589 |
| TOTAL | $189,820 | $211,681 | $233,195 | $257,960 | $282,293 |
| Non-Current Assets | |||||
| PPE Net | 13,895 | 15,113 | 16,521 | 17,740 | 19,719 |
| Investments And Advances | 2,154 | 2,154 | 3,447 | 3,447 | 10,577 |
| Other Non-Current Assets | 42,068 | 43,336 | 44,703 | 45,452 | 45,759 |
| TOTAL | $58,117 | $60,603 | $64,671 | $66,639 | $76,055 |
| Total Assets | $247,937 | $272,284 | $297,866 | $324,599 | $358,348 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,215 | 2,891 | 2,670 | 533 | 3,103 |
| Accrued Expenses | 9,897 | 5,924 | 6,120 | 8,422 | 8,840 |
| TOTAL | $29,583 | $33,265 | $39,893 | $37,309 | $45,692 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,900 | 18,942 | 25,500 | 22,762 | 29,053 |
| Other Non-Current Liabilities | 38,011 | 39,635 | 40,943 | 42,196 | 44,452 |
| TOTAL | $39,907 | $43,188 | $45,315 | $52,433 | $56,883 |
| Total Liabilities | $69,490 | $76,453 | $85,208 | $89,742 | $102,575 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,547 | 37,533 | 37,382 | 37,383 | 37,424 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -288,342 | -267,949 | -248,041 | -223,002 | -199,604 |
| Other shareholders' equity | 371 | 372 | 621 | 709 | 1,639 |
| TOTAL | $178,447 | $195,831 | $212,658 | $234,857 | $255,773 |
| Total Liabilities And Equity | $247,937 | $272,284 | $297,866 | $324,599 | $358,348 |